hVIVO, a specialist contract research organization, performs human challenge trials, helping pharma companies develop vaccines with greater efficiency. Chief scientific officer Andrew Catchpole recently spoke with In Vivo about what it takes to perform an effective human challenge study, how they keep study participants safe, and how the company is helping address the ongoing scourge of malaria.  

ENA Respiratory expects its "preventive" nasal spray, which primes innate immunity against respiratory viruses including SARS-CoV-2, to play a meaningful role in protecting at-risk populations and lowering community transmission of COVID-19. It plans to explore the potential of the broad-spectrum antiviral immunomodulator in other areas, including COPD, and wider partnering opportunities.

The SEEK spin-out ConserV Bioscience is developing a broad-spectrum coronavirus vaccine, aiming to get ahead of the arrival of new strains of the virus.

Brief summaries of recent product and company developments in the device industry, including a rift in the orthopedics industry following the DOJ settlement, new OTC aesthetics devices, and MannKind's prospects for partnering its inhaled insulin.